Highlighting the need for reliable clinical trials in glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Highlighting the need for reliable clinical trials in glioblastoma

Published:2018-07-12 Issue:10 Volume:18 Page:1031-1040
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Mandel Jacob J.¹,Youssef Michael¹,Ludmir Ethan²,Yust-Katz Shlomit³,Patel Akash J.¹,De Groot John F.⁴

Affiliation:

1. Department of Neurology, Baylor College of Medicine, Houston, Texas, USA

2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3. Department of Neurosurgery, Rabin Medical Center, Petah Tikva, Israel

4. Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1496824

Reference88 articles.

1. Malignant Gliomas in Adults

2. Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma

3. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years?

4. Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma

5. Impact of Cancer Research Bureaucracy on Innovation, Costs, and Patient Care

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Druggable genomic landscapes of high-grade gliomas;Frontiers in Medicine;2023-12-08

2. Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07

3. Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastoma;Radiation Oncology;2021-09-28

4. Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement;Clinical Cancer Research;2021-09-24

5. Imposing Phase II and Phase III Clinical Trials of Targeted Drugs for Glioblastoma: Current Status and Progress;Frontiers in Oncology;2021-09-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3